vs

Side-by-side financial comparison of AMPCO PITTSBURGH CORP (AP) and Bioceres Crop Solutions Corp. (BIOX). Click either name above to swap in a different company.

AMPCO PITTSBURGH CORP is the larger business by last-quarter revenue ($104.4M vs $77.6M, roughly 1.3× Bioceres Crop Solutions Corp.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -55.2%, a 45.6% gap on every dollar of revenue. On growth, AMPCO PITTSBURGH CORP posted the faster year-over-year revenue change (11.5% vs -16.8%). Over the past eight quarters, AMPCO PITTSBURGH CORP's revenue compounded faster (-2.6% CAGR vs -8.4%).

Ampco-Pittsburgh Corporation is a specialty steel manufacturer headquartered in Downtown Pittsburgh, Pennsylvania. It is one of several companies to bear the Ampco name, and it should not be confused with the Milwaukee-based copper base alloy producer, Ampco Metal Inc.; the Miami-based cabinetry company; the Swiss aluminum corporation; or the Dallas-based tool company. Ampco was formed in 1929 and is a conglomerate made up of several previously established small steel makers. Five small compa...

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

AP vs BIOX — Head-to-Head

Bigger by revenue
AP
AP
1.3× larger
AP
$104.4M
$77.6M
BIOX
Growing faster (revenue YoY)
AP
AP
+28.3% gap
AP
11.5%
-16.8%
BIOX
Higher net margin
BIOX
BIOX
45.6% more per $
BIOX
-9.6%
-55.2%
AP
Faster 2-yr revenue CAGR
AP
AP
Annualised
AP
-2.6%
-8.4%
BIOX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AP
AP
BIOX
BIOX
Revenue
$104.4M
$77.6M
Net Profit
$-57.7M
$-7.4M
Gross Margin
46.8%
Operating Margin
-54.0%
9.3%
Net Margin
-55.2%
-9.6%
Revenue YoY
11.5%
-16.8%
Net Profit YoY
-1958.9%
-20.2%
EPS (diluted)
$-2.87
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AP
AP
BIOX
BIOX
Q4 25
$104.4M
Q3 25
$103.7M
$77.6M
Q2 25
$108.9M
Q1 25
$99.2M
$60.6M
Q4 24
$93.6M
$98.8M
Q3 24
$92.1M
$93.3M
Q2 24
$107.1M
Q1 24
$110.0M
$84.0M
Net Profit
AP
AP
BIOX
BIOX
Q4 25
$-57.7M
Q3 25
$-2.2M
$-7.4M
Q2 25
$-7.3M
Q1 25
$1.1M
$-1.6M
Q4 24
$3.1M
$605.2K
Q3 24
$-2.0M
$-6.2M
Q2 24
$2.0M
Q1 24
$-2.7M
$9.8M
Gross Margin
AP
AP
BIOX
BIOX
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Operating Margin
AP
AP
BIOX
BIOX
Q4 25
-54.0%
Q3 25
1.1%
9.3%
Q2 25
-2.8%
Q1 25
3.9%
1.5%
Q4 24
5.5%
14.5%
Q3 24
2.0%
2.5%
Q2 24
4.7%
Q1 24
0.1%
15.7%
Net Margin
AP
AP
BIOX
BIOX
Q4 25
-55.2%
Q3 25
-2.1%
-9.6%
Q2 25
-6.7%
Q1 25
1.2%
-2.6%
Q4 24
3.3%
0.6%
Q3 24
-2.1%
-6.6%
Q2 24
1.9%
Q1 24
-2.5%
11.6%
EPS (diluted)
AP
AP
BIOX
BIOX
Q4 25
$-2.87
Q3 25
$-0.11
$-0.12
Q2 25
$-0.36
Q1 25
$0.06
$-0.02
Q4 24
$0.16
$0.00
Q3 24
$-0.10
$-0.10
Q2 24
$0.10
Q1 24
$-0.14
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AP
AP
BIOX
BIOX
Cash + ST InvestmentsLiquidity on hand
$10.7M
$15.5M
Total DebtLower is stronger
$117.9M
Stockholders' EquityBook value
$32.6M
$288.3M
Total Assets
$495.4M
$734.9M
Debt / EquityLower = less leverage
3.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AP
AP
BIOX
BIOX
Q4 25
$10.7M
Q3 25
$15.0M
$15.5M
Q2 25
$9.9M
Q1 25
$7.1M
$38.5M
Q4 24
$15.4M
$29.2M
Q3 24
$11.8M
$32.3M
Q2 24
$7.9M
Q1 24
$10.8M
$16.4M
Total Debt
AP
AP
BIOX
BIOX
Q4 25
$117.9M
Q3 25
$119.0M
Q2 25
$115.9M
Q1 25
$115.0M
Q4 24
$116.4M
Q3 24
$116.0M
Q2 24
$119.4M
Q1 24
$116.2M
Stockholders' Equity
AP
AP
BIOX
BIOX
Q4 25
$32.6M
Q3 25
$60.1M
$288.3M
Q2 25
$62.7M
Q1 25
$64.6M
$345.0M
Q4 24
$58.9M
$346.3M
Q3 24
$61.3M
$346.0M
Q2 24
$58.0M
Q1 24
$56.3M
$348.5M
Total Assets
AP
AP
BIOX
BIOX
Q4 25
$495.4M
Q3 25
$524.4M
$734.9M
Q2 25
$537.2M
Q1 25
$536.2M
$798.2M
Q4 24
$530.9M
$835.2M
Q3 24
$547.4M
$827.3M
Q2 24
$560.8M
Q1 24
$565.8M
$836.1M
Debt / Equity
AP
AP
BIOX
BIOX
Q4 25
3.61×
Q3 25
1.98×
Q2 25
1.85×
Q1 25
1.78×
Q4 24
1.98×
Q3 24
1.89×
Q2 24
2.06×
Q1 24
2.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AP
AP
BIOX
BIOX
Operating Cash FlowLast quarter
$2.7M
$14.4M
Free Cash FlowOCF − Capex
$-64.0K
FCF MarginFCF / Revenue
-0.1%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AP
AP
BIOX
BIOX
Q4 25
$2.7M
Q3 25
$6.3M
$14.4M
Q2 25
$-2.3M
Q1 25
$-5.3M
$23.3M
Q4 24
$7.5M
$-5.4M
Q3 24
$11.4M
$5.2M
Q2 24
$-5.3M
Q1 24
$4.5M
$-17.4M
Free Cash Flow
AP
AP
BIOX
BIOX
Q4 25
$-64.0K
Q3 25
$3.3M
Q2 25
$-3.8M
Q1 25
$-7.5M
Q4 24
$3.7M
Q3 24
$8.4M
Q2 24
$-8.0M
Q1 24
$1.7M
FCF Margin
AP
AP
BIOX
BIOX
Q4 25
-0.1%
Q3 25
3.2%
Q2 25
-3.5%
Q1 25
-7.5%
Q4 24
4.0%
Q3 24
9.1%
Q2 24
-7.5%
Q1 24
1.5%
Capex Intensity
AP
AP
BIOX
BIOX
Q4 25
2.7%
Q3 25
2.9%
Q2 25
1.3%
Q1 25
2.2%
Q4 24
4.0%
Q3 24
3.2%
Q2 24
2.5%
Q1 24
2.6%
Cash Conversion
AP
AP
BIOX
BIOX
Q4 25
Q3 25
Q2 25
Q1 25
-4.62×
Q4 24
2.40×
-8.85×
Q3 24
Q2 24
-2.64×
Q1 24
-1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AP
AP

Forged And Cast Mill Rolls$67.0M64%
Air Handling Systems$14.3M14%
Heat Exchange Coils$13.1M13%
Centrifugal Pumps$10.3M10%
Forged Engineered Products$4.0M4%

BIOX
BIOX

Segment breakdown not available.

Related Comparisons